Clinical Trial Update: Methadone to Treat Painful Chemotherapy Induced Peripheral Neuropathy [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial evaluating methadone for painful chemotherapy-induced peripheral neuropathy. The study is in Phase 2/Phase 3 and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• Methadone (methadone)

Snippet

Sponsor: University of British Columbia | Conditions: Chemotherapy-induced Peripheral Neuropathy | Phase 2, Phase 3 | Status: RECRUITING